Skip to Main Content

Paper Details

Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer.
Gulf J Oncolog
1
2021
Author NameAffiliation
Mike PauldenSchool of Public Health, University of Alberta
  • 1 - 1

Datasets

Release 1.2